CTEV — Claritev Corporation

CTEV Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Q4 Revenue: $246.6 million, up 6.2% year-over-year.
• Full Year Revenue: $965.4 million, a 3.7% increase from 2024.
• Adjusted EBITDA for Q4: $151.3 million, a 7% increase with a margin of 61.4%.
• Levered Free Cash Flow for Q4: $36.4 million.
• Net Leverage Ratio: 7.7x, improved from previous levels.
• Bookings: Record $23 million in Q4, with total annual ACV booked at $67 million.

2. Strategic Updates and Business Highlights:

• Claritev is focused on a long-term strategic plan, Vision 2030, emphasizing sustainable, profitable growth in healthcare technology.
• The company has made significant progress in digital transformation, enhancing operational efficiency and product offerings.
• New solutions, such as the "Network Builder," allow for rapid creation of tailored healthcare networks, improving client service.
• Expansion into international markets, particularly in the Middle East, with two new client signings.
• Continued success in renewing top clients and expanding solutions in key areas like Payment & Revenue Integrity.

3. Forward Guidance and Outlook:

• 2026 Revenue Guidance: $980 million to $1 billion, representing 2% to 4% growth over 2025.
• Adjusted EBITDA Guidance for 2026: $605 million to $615 million, with margins of 61% to 62%.
• Expected strong double-digit ACV bookings growth in 2026, with a robust pipeline already established.
• Anticipated shift of some capitalized costs to OpEx due to cloud transition, impacting adjusted EBITDA but no cash flow effect.

4. Bad News, Challenges, or Points of Concern:

• The company will face a headwind from approximately $18 million of one-time revenue in 2025 that will not recur in 2026.
• Transitioning costs from capital expenditures to operating expenses may pressure margins in the short term.
• The healthcare industry remains complex and fragmented, with ongoing challenges such as rising costs, regulatory changes, and payer-provider friction.

5. Notable Q&A Insights:

• The call experienced audio issues, leading to a brief pause and a shift to a different line for clarity.
• Management emphasized the importance of trust and data integrity in maintaining client relationships and competitive advantage.
• Claritev's commitment to AI as a transformative force in healthcare was highlighted, with expectations that it will enhance operational efficiency and client outcomes.
• The management team expressed confidence in navigating market challenges and leveraging their competitive advantages to drive future growth.

Overall, Claritev's Q4 2025 results indicate a solid performance with a positive outlook for 2026, despite some anticipated challenges. The company is strategically positioned to capitalize on market opportunities through innovation and client-focused solutions.